US Broker Ratings

Guardant Health, Inc. (GH)

⚠️ No article content returned.

..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Growth Amid Challenging Metrics

Oscar Health, Inc. (NYSE: OSCR) is making waves in the healthcare sector with its innovative approach to health plans and technology-driven services. With a market capitalization of $5.57 billion, the..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Uncovering a 34% Potential Upside in the Biotech Sector

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is a name that should capture investor attention, not only for its innovative contributions to the biotechnology field but also for its compelling potential upside..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: Exploring a 31% Upside Potential in the Biotech Sector

Madrigal Pharmaceuticals, Inc. (MDGL), a key player in the biotech sector, presents a compelling opportunity for investors seeking exposure to cutting-edge therapeutics in the healthcare industry. With a market cap..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Is a 52.44% Upside Just Around the Corner?

iRhythm Holdings, Inc. (NASDAQ: IRTC) has captured the attention of the healthcare investment community with its innovative approach to cardiac monitoring technology. As a leader in the medical devices industry,..

Moderna, Inc. (MRNA) Stock Analysis: Navigating Biotech’s Challenges with 260% Revenue Growth

Moderna, Inc. (NASDAQ: MRNA) has firmly established itself as a pivotal player in the biotechnology sector, particularly in the realm of mRNA-based therapeutics. With a market capitalization of $17.99 billion,..

Ascendis Pharma A/S (ASND) Stock Analysis: A 34% Potential Upside Beckons Investors

In the dynamic world of biotechnology, Ascendis Pharma A/S (NASDAQ: ASND) is gaining attention with a promising 34.45% potential upside, according to analyst ratings. As a biopharmaceutical company headquartered in..

Inspire Medical Systems, Inc. (INSP) Investor Outlook: A Healthcare Innovator with a 27% Upside Potential

For investors seeking exposure to the healthcare sector, Inspire Medical Systems, Inc. (NYSE: INSP) presents a compelling opportunity. Specializing in innovative medical devices for treating obstructive sleep apnea (OSA), Inspire..

Vaxcyte, Inc. (PCVX) Investor Outlook: Analyzing a 91% Potential Upside in the Biotech Sector

Vaxcyte, Inc. (NASDAQ: PCVX), a burgeoning entity in the biotechnology sector, has captured the attention of investors with its promising portfolio of vaccine candidates and an impressive potential upside of..

Biogen Inc. (BIIB) Investor Outlook: Exploring a 16% Potential Upside with Strong Buy Ratings

Biogen Inc. (BIIB), a leading player in the healthcare sector, particularly in the drug manufacturing industry, presents an intriguing opportunity for investors. With a market capitalization of $27.62 billion, the..

The Ensign Group, Inc. (ENSG) Investor Outlook: A 20% Upside with Strong Buy Ratings

The Ensign Group, Inc. (NASDAQ: ENSG) stands as a formidable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $10.73 billion, this..

RadNet, Inc. (RDNT) Stock Analysis: A 58% Potential Upside Driven by Diagnostic Innovation

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector, offers a compelling opportunity for investors looking to capitalize on the growing demand for diagnostic imaging services. The company,..

Baxter International Inc. (BAX) Stock Analysis: Exploring a 28.5% Potential Upside for Healthcare Investors

Baxter International Inc. (NYSE: BAX) stands at an intriguing juncture for investors seeking opportunities in the healthcare sector. With its current market capitalization at $8.88 billion, Baxter is a prominent..

Labcorp Holdings Inc. (LH) Stock Analysis: A 21% Potential Upside That Investors Can’t Ignore

For those with a keen eye on the healthcare sector, Labcorp Holdings Inc. (NYSE: LH) presents an intriguing investment opportunity. With a market capitalization of $21.06 billion, this major player..

BioNTech SE (BNTX) Stock Analysis: Unveiling a 33.91% Potential Upside in the Biotech Sector

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has captured the spotlight of global investors following its pivotal role in developing the mRNA vaccine for COVID-19. Headquartered..

Align Technology, Inc. (ALGN) Investor Outlook: Exploring a 16.86% Upside Potential

Align Technology, Inc. (NASDAQ: ALGN), a prominent player in the healthcare sector, is capturing investor attention with its innovative orthodontic and digital scanning solutions. With a market capitalization of $12.81..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unveiling a 92% Upside Potential in the Biotech Sector

Telix Pharmaceuticals Limited (ASX: TLX), a frontrunner in the biotechnology sector, presents an intriguing investment opportunity with a compelling 92% potential upside based on analyst target prices. With a market..

United Therapeutics Corporation (UTHR) Stock Analysis: Navigating Growth and Innovation in Healthcare

United Therapeutics Corporation (NASDAQ: UTHR) has been making waves in the healthcare sector with its robust pipeline and innovative treatments targeting chronic and life-threatening diseases. With a market cap of..

STERIS plc (STE) Stock Analysis: Exploring a Promising 30% Upside Potential

Investors eyeing the healthcare sector might find STERIS plc (STE) an intriguing prospect, especially given its potential upside of over 30% based on analyst target prices. With a market cap..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Unveiling a 31% Potential Upside

As the healthcare landscape continues to evolve, GE HealthCare Technologies Inc. (NYSE: GEHC) stands out as a key player in the medical devices industry, boasting a robust market capitalization of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds